TABLE 3.

AQ‐10 scores at study enrolment and their association with clinical outcomes at 1‐year (n = 160)

Clinical outcomes	ORa	95% CI	P value
Symptomatic remission	0.86	0.70‐1.05	.14
Functional remission	0.86	0.72‐1.03	.10
	β b	95% CI	P value	Partial eta square
Improvements in PANSSc
Positive scale	−0.18	−0.44 to 0.09	.19	0.01
Negative scale	−0.38	−0.82 to 0.07	.10	0.02
General psychopathology scale	−0.61	−1.13 to −0.09	.02*	0.03
Improvements in GAFc
Symptomatology	−0.80	−1.55 to −0.06	.03*	0.03
Disability	−0.71	−1.44 to 0.19	.06	0.02

Abbreviations: GAF, Global Assessment of Functioning; PANSS, Positive and Negative Syndrome Scale.

^a Odds ratio obtained using multiple logistic regression where AQ‐10 score was treated as the main predictor; adjusted for age, gender, duration of untreated psychosis, baseline employment, DSM‐IV diagnosis and corresponding variable at baseline.

^b Beta coefficient was obtained using multiple linear regression where AQ‐10 score was treated as main predictor; adjusted for age, gender, duration of untreated psychosis, baseline employment, DSM‐IV diagnosis and corresponding variable at baseline.

^c Improvements are defined as the change in raw score of the variable of interest between baseline and 1 year.

^*Significant at P ≤ .05.